by Compiled by Laskey Hart and Shawn Lawrence •
February 7, 2017 •
Editor's Picks, Podcast •
Comments (0) •
Accelerating precision medicine for cancer patients, Avivagen partners with NRC in tackling antibiotic resistance in humans, and Knight buys in on an Israeli biotech company. We have all this and more on this week’s Biotechnology Focus Podcast.
Comments are closed.
© 2017 Biotechnology Focus™
Powered by Wordpress. Designed by Themnific™